QuidelOrtho Corporation (NASDAQ:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine,
QuidelOrtho Corporation (NASDAQ:QDEL) ("QuidelOrtho" or the "Company"), a global provider of innovative in vitro diagnostic (IVD) technologies designed for point-of-care settings, clinical labs
Quidel (NASDAQ:QDEL) reported quarterly earnings of $1.85 per share which beat the analyst consensus estimate of $0.74 by 150 percent. This is a 65.49 percent decrease over earnings of $5.36 per share from the same